1. Home
  2. VRNA vs TTEK Comparison

VRNA vs TTEK Comparison

Compare VRNA & TTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • TTEK
  • Stock Information
  • Founded
  • VRNA 2005
  • TTEK 1966
  • Country
  • VRNA United Kingdom
  • TTEK United States
  • Employees
  • VRNA N/A
  • TTEK N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • TTEK Military/Government/Technical
  • Sector
  • VRNA Health Care
  • TTEK Consumer Discretionary
  • Exchange
  • VRNA Nasdaq
  • TTEK Nasdaq
  • Market Cap
  • VRNA 8.3B
  • TTEK 9.4B
  • IPO Year
  • VRNA 2017
  • TTEK 1991
  • Fundamental
  • Price
  • VRNA $105.79
  • TTEK $36.91
  • Analyst Decision
  • VRNA Buy
  • TTEK Buy
  • Analyst Count
  • VRNA 11
  • TTEK 5
  • Target Price
  • VRNA $114.10
  • TTEK $42.25
  • AVG Volume (30 Days)
  • VRNA 1.4M
  • TTEK 1.9M
  • Earning Date
  • VRNA 08-06-2025
  • TTEK 07-30-2025
  • Dividend Yield
  • VRNA N/A
  • TTEK 0.71%
  • EPS Growth
  • VRNA N/A
  • TTEK N/A
  • EPS
  • VRNA N/A
  • TTEK 0.80
  • Revenue
  • VRNA $221,673,000.00
  • TTEK $4,598,536,000.00
  • Revenue This Year
  • VRNA $896.59
  • TTEK $6.67
  • Revenue Next Year
  • VRNA $77.56
  • TTEK N/A
  • P/E Ratio
  • VRNA N/A
  • TTEK $45.89
  • Revenue Growth
  • VRNA N/A
  • TTEK 8.59
  • 52 Week Low
  • VRNA $24.50
  • TTEK $27.27
  • 52 Week High
  • VRNA $105.89
  • TTEK $51.20
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 68.01
  • TTEK 53.31
  • Support Level
  • VRNA $105.23
  • TTEK $36.22
  • Resistance Level
  • VRNA $105.81
  • TTEK $37.17
  • Average True Range (ATR)
  • VRNA 0.25
  • TTEK 0.74
  • MACD
  • VRNA -0.36
  • TTEK 0.07
  • Stochastic Oscillator
  • VRNA 87.88
  • TTEK 81.31

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About TTEK Tetra Tech Inc.

Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. Tetra Tech has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.

Share on Social Networks: